Nuveen Portfolio holdings
Nuveen is the asset management arm of TIAA, a financial services group long focused on retirement savings for universities, other not-for-profit institutions and their employees. Nuveen manages all of TIAA's capital as well as money from outside investors, and began in Chicago in 1898 as John Nuveen & Company, an investment bank founded by John Nuveen Sr. to underwrite and sell municipal bonds. Its funds cover income, equity, real estate and real assets such as farmland and timberland, alongside private equity and private debt, and Nuveen and TIAA often invest their own money alongside clients. A private equity group led by Madison Dearborn Partners bought the firm in 2007, and it merged with TIAA in 2014.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$944M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$593M |
| 3 |
Sandisk
SNDK
|
+$559M |
| 4 |
Booking.com
BKNG
|
+$521M |
| 5 |
Micron Technology
MU
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.07B |
| 2 |
Microsoft
MSFT
|
+$1.51B |
| 3 |
NVIDIA
NVDA
|
+$1.18B |
| 4 |
Apple
AAPL
|
+$1.04B |
| 5 |
Broadcom
AVGO
|
+$949M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.08% |
| 2 | Financials | 10.73% |
| 3 | Industrials | 10.3% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Healthcare | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Bath & Body Works
BBWI
$4.39B
| $5.72M | ﹤0.01% |
247,392
-40,344
| -14% | -$772K |
2019 Q2
28 quarters
|
|
2002
BancFirst
BANF
$3.96B
| $5.71M | ﹤0.01% |
51,347
+5,198
| +11% | +$582K |
2019 Q2
28 quarters
|
|
2003
Capricor Therapeutics
CAPR
$573M
| $5.7M | ﹤0.01% |
236,612
+73,706
| +45% | +$2.23M |
2024 Q2
8 quarters
|
|
2004
Innovative Industrial Properties
IIPR
$1.53B
| $5.69M | ﹤0.01% |
91,732
+25,854
| +39% | +$1.45M |
2019 Q2
28 quarters
|
|
2005
DHT Holdings
DHT
$3.32B
| $5.66M | ﹤0.01% |
342,311
-768,072
| -69% | -$13.7M |
2019 Q2
28 quarters
|
|
2006
ScottsMiracle-Gro
SMG
$3.86B
| $5.64M | ﹤0.01% |
82,853
-133,902
| -62% | -$8.29M |
2019 Q2
28 quarters
|
|
2007
BOK Financial
BOKF
$7.99B
| $5.64M | ﹤0.01% |
40,632
+6,730
| +20% | +$889K |
2019 Q2
28 quarters
|
|
2008
Insperity
NSP
$1.88B
| $5.61M | ﹤0.01% |
135,824
+56,033
| +70% | +$1.84M |
2019 Q2
28 quarters
|
|
2009
Apogee Enterprises
APOG
$1B
| $5.61M | ﹤0.01% |
122,609
+73,738
| +151% | +$2.75M |
2019 Q2
28 quarters
|
|
2010
Avis
CAR
$4.51B
| $5.6M | ﹤0.01% |
37,883
+4,401
| +13% | +$969K |
2019 Q2
28 quarters
|
|
2011
Sally Beauty Holdings
SBH
$1.82B
| $5.58M | ﹤0.01% |
394,493
+7,190
| +2% | +$97K |
2017 Q3
35 quarters
|
|
2012
Sutro Biopharma
STRO
$176M
| $5.58M | ﹤0.01% |
+167,997
| New | +$5.24M |
2026 Q2
0 quarters
|
|
2013
Lindsay Corp
LNN
$1.12B
| $5.57M | ﹤0.01% |
44,980
+16,634
| +59% | +$1.86M |
2019 Q2
28 quarters
|
|
2014
Intrepid Potash
IPI
$445M
| $5.56M | ﹤0.01% |
169,711
+55,502
| +49% | +$2.11M |
2019 Q2
28 quarters
|
|
2015
Ibotta
IBTA
$1.41B
| $5.55M | ﹤0.01% |
162,509
+110,489
| +212% | +$3.69M |
2024 Q2
8 quarters
|
|
2016
Dynex Capital
DX
$2.81B
| $5.55M | ﹤0.01% |
423,407
+53,527
| +14% | +$704K |
2019 Q2
28 quarters
|
|
2017
Castle Biosciences
CSTL
$1.06B
| $5.53M | ﹤0.01% |
231,726
-290,401
| -56% | -$6.47M |
2019 Q3
27 quarters
|
|
2018
Figma
FIG
$10.4B
| $5.51M | ﹤0.01% |
304,801
-2,056,849
| -87% | -$41.4M |
2025 Q3
3 quarters
|
|
2019
Amprius Technologies
AMPX
$1.39B
| $5.51M | ﹤0.01% |
397,802
+153,907
| +63% | +$2.76M |
2023 Q4
10 quarters
|
|
2020
Zegna
ZGN
$3.86B
| $5.51M | ﹤0.01% |
422,886
+336,207
| +388% | +$4.34M |
2022 Q2
16 quarters
|
|
2021
PAR Technology
PAR
$902M
| $5.49M | ﹤0.01% |
314,870
+190,393
| +153% | +$2.75M |
2019 Q2
28 quarters
|
|
2022
Brookfield
BN
$95.9B
| $5.46M | ﹤0.01% |
128,245
+46,522
| +57% | +$2.08M |
2026 Q1
1 quarter
|
|
2023
Prothena Corp
PRTA
$451M
| $5.45M | ﹤0.01% |
557,157
-202,211
| -27% | -$2M |
2019 Q2
28 quarters
|
|
2024
MBX Biosciences
MBX
$2.6B
| $5.45M | ﹤0.01% |
98,733
+16,941
| +21% | +$592K |
2024 Q4
6 quarters
|
|
2025
FB Financial Corp
FBK
$2.7B
| $5.44M | ﹤0.01% |
98,347
-84,475
| -46% | -$4.54M |
2019 Q2
28 quarters
|
|
Similar funds
Nuveen's Q2 2026 Portfolio in Review
As of Q2 2026, Nuveen held 3,870 positions worth $419B, up 14% from $369B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Nuveen's Q2 2026 filing shows 648 new, 1,897 increased, 998 reduced and 136 closed positions. Its largest new stake was Honeywell Aerospace: 2,688,848 shares worth $594M. The largest sale was Amazon, an estimated $2.07B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Nuveen's largest Q2 2026 buy was Honeywell Aerospace: 2,688,848 shares worth $594M.
- Nuveen added most to Tesla in Q2 2026, an estimated $944M increase.
- Nuveen's biggest Q2 2026 reduction was Amazon, cutting an estimated $2.07B.
- Nuveen fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, selling an estimated $393M.
- Nuveen's ten largest holdings make up 31% of its $419B portfolio in Q2 2026.
- Nuveen opened 648 new positions and closed 136 in Q2 2026.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $419B.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.